Investors remain bullish on medical device makers, expecting them to benefit from still-high demand for surgical procedures, ...

Study Reveals Why Newborns Can Regenerate Heart Tissue While Adults Struggle After a Heart AttackA new study in experimental animals reveals a ...

Despite guideline recommendations, the use of bioprosthetic heart valves has surpassed mechanical valves, but data from a large surgical database may lead to a reassessment of that practice.

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has found.

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research led by the University of Bristol ...

The Heart Valve Devices Market is driven by advancements in aortic, mitral, tricuspid, and pulmonary valve technologies. It includes biological and m ...

Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

Philippe Pibarot, Professor of Medicine and Director of the Canada Research Chair in Valvular Heart Diseases at Laval University Jean G. Dumesnil, Professor of Medicine and a Cardiologist at Laval ...

For some patients with atrial fibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) appeared to offer better prevention of stroke and thromboembolic events ...